decisionhealth Newsletters, Coder Pink Sheets - 2006 Issue 8 (August)
Ortho practices take dim view of Medicare drug CAP
Subscribe or sign in to view the full article.
Article Overview
This article discusses Medicare’s Competitive Acquisition Program (CAP) in the context of orthopedic practices and injectable drug reimbursement. It explains the program’s rollout, provider participation, and operational implications, then compares commonly billed orthopedic drug codes with whether they were available through CAP and the associated Medicare payment rates. The piece is most relevant to orthopedic billing staff, coding professionals, practice managers, and reimbursement analysts evaluating Medicare drug acquisition options.
Why This Topic Matters
The article helps readers understand a Medicare drug-purchasing program that could change how orthopedic practices obtain and bill for injectable medications. It is useful for assessing administrative impact, vendor participation, and the relationship between practice costs and Medicare payment levels.
Article Sections
-
Ortho practices take dim view of Medicare drug CAP
Introduces the topic and summarizes orthopedic practice reactions to Medicare’s drug acquisition program. It frames the discussion around physician reimbursement, practice economics, and administrative burden.
-
What it is
Provides background on the Medicare program, its implementation timeline, participation levels, and vendor involvement. It also outlines the general operating structure of the program.
-
CAP would eat up your drug revenue
Discusses the program’s potential impact on practice revenue and workflow from a consultant and practice-management perspective. The section compares purchasing and overhead considerations in broad terms.
-
You don’t lose the overhead
Continues the operational discussion by addressing staff time, ordering processes, and paperwork implications. It notes that the program may affect practices differently depending on their purchasing and inventory situation.
-
Top Ortho Drugs and CAP
Presents a comparative table of commonly billed orthopedic injectable drug codes, CAP availability, brand associations, utilization, and Medicare payment information. The section serves as a reference for evaluating which high-volume items were included in the program.
-
Resources
Lists a source for additional information about the program and related Medicare guidance.
What You Will Learn
- How Medicare’s Competitive Acquisition Program was positioned for physician drug purchasing
- How orthopedic practices viewed the program’s possible impact on revenue and workflow
- Which broad categories of commonly billed orthopedic injectable drugs were discussed in relation to CAP
- Where to find additional program information from CMS
Who Should Read This
- Orthopedic coders
- Medical billers
- Practice managers
- Reimbursement analysts
- Physician office administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com